EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oleoylethanolamide Treatment Modulates Both Neuroinflammation and Microgliosis, and Prevents Massive Leukocyte Infiltration to the Cerebellum in a Mouse Model of Neuronal Degeneration

Ester Pérez-Martín iD, Laura Pérez-Revuelta iD, Cristina Barahona-López iD, David Pérez-Boyero iD, José R Alonso iD, David Díaz iD, Eduardo Weruaga iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24119691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ester Pérez-Martín und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuronal Plasticity and Neurorepair, Institute of Neuroscience of Castile and Leon (INCyL), Universidad de Salamanca, 37007 Salamanca, …. Hauptthemen laut MEDLINE: Neuroinflammatory Diseases, PPAR alpha. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Science and Innovation, Ministry of Science and Innovation/Universities, Regional Government of Castile and Leon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases involve an exacerbated neuroinflammatory response led by microglia that triggers cytokine storm and leukocyte infiltration into the brain. PPARα agonists partially dampen this neuroinflammation in some models of brain insult, but neuronal loss was not the triggering cause in any of them. This study examines the anti-inflammatory and immunomodulatory properties of the PPARα agonist oleoylethanolamide (OEA) in the Purkinje Cell Degeneration (PCD) mouse, which exhibits striking neuroinflammation caused by aggressive loss of cerebellar Purkinje neurons. Using real-time quantitative polymerase chain reaction and immunostaining, we quantified changes in pro- and anti-inflammatory markers, microglial density and marker-based phenotype, and overall leukocyte recruitment at different time points after OEA administration. OEA was found to modulate cerebellar neuroinflammation by increasing the gene expression of proinflammatory mediators at the onset of neurodegeneration and decreasing it over time. OEA also enhanced the expression of anti-inflammatory and neuroprotective factors and the Pparα gene. Regarding microgliosis, OEA reduced microglial density—especially in regions where it is preferentially located in PCD mice—and shifted the microglial phenotype towards an anti-inflammatory state. Finally, OEA prevented massive leukocyte infiltration into the cerebellum. Overall, our findings suggest that OEA may change the environment to protect neurons from degeneration caused by exacerbated inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroinflammatory DiseasesPPAR alphaMiceAnimalsDisease Models, AnimalOleic AcidsEndocannabinoidsCerebellumAnti-Inflammatory AgentsEthanolamine

Stichwörter der Autor:innen

PCD mousePurkinje cellsendocannabinoidsmicroglianeurodegenerationneuroinflammationneurotherapeuticsoleoylethanolamide (OEA)

Substanzen

PPAR alphaOleic AcidsEndocannabinoidsAnti-Inflammatory Agentsoleoylethanolamideoleoyl ethanolamineEthanolamine

Autor:innen und Institutionen

  • Laboratory of Neuronal Plasticity and Neurorepair, Institute of Neuroscience of Castile and Leon (INCyL), Universidad de Salamanca, 37007 Salamanca, Spain.
  • Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.

ORCID-Profile: Ester Pérez-Martín, Laura Pérez-Revuelta, Cristina Barahona-López, David Pérez-Boyero, José R Alonso, David Díaz, Eduardo Weruaga

Förderung

  • Spanish Ministry of Science and Innovation
  • Ministry of Science and Innovation/Universities
  • Regional Government of Castile and Leon
  • Centre for Regenerative Medicine
  • University of Salamanca

Zitieren

APA

Pérez-Martín, E., Pérez-Revuelta, L., Barahona-López, C., Pérez-Boyero, D., Alonso, J. R., Díaz, D., & Weruaga, E. (2023). Oleoylethanolamide Treatment Modulates Both Neuroinflammation and Microgliosis, and Prevents Massive Leukocyte Infiltration to the Cerebellum in a Mouse Model of Neuronal Degeneration. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119691

Vancouver

Pérez-Martín E, Pérez-Revuelta L, Barahona-López C, Pérez-Boyero D, Alonso JR, Díaz D, et al. Oleoylethanolamide Treatment Modulates Both Neuroinflammation and Microgliosis, and Prevents Massive Leukocyte Infiltration to the Cerebellum in a Mouse Model of Neuronal Degeneration. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119691

BibTeX
@article{PrezMartn2023,
  author = {Pérez-Martín, Ester and Pérez-Revuelta, Laura and Barahona-López, Cristina and Pérez-Boyero, David and Alonso, José R and Díaz, David and Weruaga, Eduardo},
  title = {Oleoylethanolamide Treatment Modulates Both Neuroinflammation and Microgliosis, and Prevents Massive Leukocyte Infiltration to the Cerebellum in a Mouse Model of Neuronal Degeneration},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24119691}
}
Kostenlos starten →